标普生物科技LOF(161127)
动态评分: 5.42分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2020-12-31 | RNA | Avidity Biosciences Inc | 11.87 | 0.13% |
2020-12-31 | GBIO | Generation Bio Co | 10.91 | 0.12% |
2020-12-31 | NLTX | Neoleukin Therapeutics Inc | 10.55 | 0.12% |
2020-12-31 | BCEL | Atreca Inc-A | 9.69 | 0.11% |
2020-12-31 | NRIX | Nurix Therapeutics Inc | 9.93 | 0.11% |
2020-12-31 | CTMX | CytomX Therapeutics Inc | 8.58 | 0.1% |
2020-12-31 | FPRX | Five Prime Therapeutics Inc | 8.5 | 0.1% |
2020-12-31 | ARDX | Ardelyx Inc | 8.45 | 0.09% |
2020-12-31 | RCEL | AVITA Medical Inc | 6.23 | 0.07% |
2020-09-30 | IMMU | Immunomedics Inc | 138.45 | 1.76% |
2020-09-30 | SRNE | Sorrento Therapeutics Inc | 121.35 | 1.55% |
2020-09-30 | BPMC | Blueprint Medicines Corp | 95.96 | 1.22% |
2020-09-30 | EXAS | 精密科学 | 91.99 | 1.17% |
2020-09-30 | NVTA | Invitae Corp | 91.67 | 1.17% |
2020-09-30 | ARWR | Arrowhead Pharmaceuticals Inc | 89.2 | 1.14% |
2020-09-30 | SGEN | Seagen Inc | 89.82 | 1.14% |
2020-09-30 | MRTX | Mirati Therapeutics Inc | 86.51 | 1.1% |
2020-09-30 | XLRN | Acceleron Pharma Inc | 85.68 | 1.09% |
2020-09-30 | OPK | OPKO健康 | 84.89 | 1.08% |
2020-06-30 | INO | Inovio制药 | 199.38 | 1.92% |
公告&资料
